Caribou Biosciences (NASDAQ:CRBU – Get Free Report) and iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations. Earnings & Valuation This table compares Caribou […]
Caribou Biosciences (NASDAQ:CRBU – Get Free Report) and iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, dividends, valuation and analyst recommendations. Earnings and Valuation This table compares Caribou […]
ITeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Equities researchers at HC Wainwright boosted their Q1 2024 earnings estimates for shares of iTeos Therapeutics in a research report issued on Thursday, March 7th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($1.22) per share for the quarter, up from their prior […]
ITeos Therapeutics (NASDAQ:ITOS – Get Free Report) and Inhibrx (NASDAQ:INBX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation. Analyst Recommendations This is a breakdown of recent […]
ITeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Equities research analysts at HC Wainwright boosted their FY2023 EPS estimates for iTeos Therapeutics in a research report issued to clients and investors on Wednesday, November 8th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings of ($3.84) per share for the year, […]